Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Cell death : An anti-rejection drug for the treatment of Huntington’s disease

07.02.2006


At the Institut Curie, CNRS and Inserm researchers have shown that Huntington’s disease may be treated using the drug FK506, which is also used clinically to prevent graft rejection. Like Alzheimer’s and Parkinson’s, Huntington’s disease is characterized by the abnormal death of neurons.



The Institut Curie researchers have discovered that FK506 blocks the toxicity of the protein huntingtin, which causes the death of certain neurons leading to disease onset. FK506 is already used in a clinical setting and so is a candidate for fast-track development as a treatment for Huntington’s disease.

This study was published in the February 1, 2006 issue of The Journal of Neuroscience.


Huntington’s disease is a genetic disorder which affects approximately 6 000 people in France and is of concern to over 12 000 carriers of the mutated gene as yet untouched by clinical signs. It is characterized by uncontrolled movements, personality changes, dementia and death 10 to 20 years after onset of the first symptoms (see "Additional information").

Huntington’s disease results from changes in the IT15 gene, which encodes a protein, huntingtin, whose function is incompletely elucidated. Normal huntingtin contains repeats of the amino acid glutamine, but mutant huntingtin contains more than 35 to 40 glutamines and induces the disease. Symptoms occur earlier as the number of repeats increases.

This abnormal expansion of the polyglutamine tract in huntingtin results in structural changes, and the mutant huntingtin accumulates in neurons thereby causing their dysfunction and ultimately their death.

The same type of mutation causes other neurodegenerative diseases, each involving different regions of the brain. In Huntington’s disease, degeneration occurs in the neurons of the striatum, which are involved in the control of movement.

Raúl Pardo and Emilie Colin at the Institut Curie are studying the mechanisms that lead to neuron death in Huntington’s disease, under the direction of Frédéric Saudou and Sandrine Humbert(1).

They have now shown that calcineurin, a protein abundant in the brain, chemically alters mutant huntingtin, which becomes more toxic for neurons.

They have also discovered that by inhibiting calcineurin, FK506 “corrects” this chemical alteration in mutant huntingtin both in cultured neurons and in an animal model of the disease. FK506 even prevents the death of the striatal neurons. So, FK506 negates the harmful effects of mutant huntingtin in neurons.

FK506 is already used therapeutically to prevent graft rejection, and so may be a candidate for fast-track development as a treatment for Huntington’s disease.

Catherine Goupillon | alfa
Further information:
http://www.jneurosci.org/
http://www.curie.fr

More articles from Life Sciences:

nachricht At last, butterflies get a bigger, better evolutionary tree
16.02.2018 | Florida Museum of Natural History

nachricht New treatment strategies for chronic kidney disease from the animal kingdom
16.02.2018 | Veterinärmedizinische Universität Wien

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

Im Focus: Hybrid optics bring color imaging using ultrathin metalenses into focus

For photographers and scientists, lenses are lifesavers. They reflect and refract light, making possible the imaging systems that drive discovery through the microscope and preserve history through cameras.

But today's glass-based lenses are bulky and resist miniaturization. Next-generation technologies, such as ultrathin cameras or tiny microscopes, require...

Im Focus: Stem cell divisions in the adult brain seen for the first time

Scientists from the University of Zurich have succeeded for the first time in tracking individual stem cells and their neuronal progeny over months within the intact adult brain. This study sheds light on how new neurons are produced throughout life.

The generation of new nerve cells was once thought to taper off at the end of embryonic development. However, recent research has shown that the adult brain...

Im Focus: Interference as a new method for cooling quantum devices

Theoretical physicists propose to use negative interference to control heat flow in quantum devices. Study published in Physical Review Letters

Quantum computer parts are sensitive and need to be cooled to very low temperatures. Their tiny size makes them particularly susceptible to a temperature...

Im Focus: Autonomous 3D scanner supports individual manufacturing processes

Let’s say the armrest is broken in your vintage car. As things stand, you would need a lot of luck and persistence to find the right spare part. But in the world of Industrie 4.0 and production with batch sizes of one, you can simply scan the armrest and print it out. This is made possible by the first ever 3D scanner capable of working autonomously and in real time. The autonomous scanning system will be on display at the Hannover Messe Preview on February 6 and at the Hannover Messe proper from April 23 to 27, 2018 (Hall 6, Booth A30).

Part of the charm of vintage cars is that they stopped making them long ago, so it is special when you do see one out on the roads. If something breaks or...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on High Temperature Shape Memory Alloys (HTSMAs)

15.02.2018 | Event News

Aachen DC Grid Summit 2018

13.02.2018 | Event News

How Global Climate Policy Can Learn from the Energy Transition

12.02.2018 | Event News

 
Latest News

Fingerprints of quantum entanglement

16.02.2018 | Information Technology

'Living bandages': NUST MISIS scientists develop biocompatible anti-burn nanofibers

16.02.2018 | Health and Medicine

Hubble sees Neptune's mysterious shrinking storm

16.02.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>